PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
This Quarter Return
-14.48%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$4.99B
AUM Growth
+$4.99B
Cap. Flow
-$278M
Cap. Flow %
-5.57%
Top 10 Hldgs %
44.72%
Holding
161
New
13
Increased
22
Reduced
36
Closed
22

Top Buys

1
CINC
CinCor Pharma, Inc. Common Stock
CINC
$40.7M
2
IOVA icon
Iovance Biotherapeutics
IOVA
$34.5M
3
NVRO
NEVRO CORP.
NVRO
$32.8M
4
PEN icon
Penumbra
PEN
$31.9M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
$29.4M

Top Sells

1
BMRN icon
BioMarin Pharmaceuticals
BMRN
$104M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$74.3M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
$46.5M
4
KOD icon
Kodiak Sciences
KOD
$44.1M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$40M

Sector Composition

1 Healthcare 82.09%
2 Financials 0.49%
3 Industrials 0.12%
4 Consumer Discretionary 0.03%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ATHA icon
26
Athira Pharma
ATHA
$15.5M
$46.3M 0.93%
3,425,916
– –
ALDX icon
27
Aldeyra Therapeutics
ALDX
$350M
$44M 0.88%
9,903,879
– –
CCXI
28
DELISTED
ChemoCentryx, Inc.
CCXI
$41.5M 0.83%
1,655,079
+239,633
+17% +$6.01M
CINC
29
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$40.7M 0.81%
+2,319,117
New +$40.7M
INBX
30
DELISTED
Inhibrx, Inc. Common Stock
INBX
$39.7M 0.79%
1,781,235
+437,745
+33% +$9.75M
NAUT icon
31
Nautilus Biotechnolgy
NAUT
$80.7M
$39.5M 0.79%
9,111,151
– –
BBIO icon
32
BridgeBio Pharma
BBIO
$9.91B
$39M 0.78%
3,839,380
-3,289,375
-46% -$33.4M
NBIX icon
33
Neurocrine Biosciences
NBIX
$13.5B
$37.1M 0.74%
395,639
-87,368
-18% -$8.19M
ZYME icon
34
Zymeworks
ZYME
$1.07B
$34.9M 0.7%
5,325,615
+1,645,770
+45% +$10.8M
NVRO
35
DELISTED
NEVRO CORP.
NVRO
$34.5M 0.69%
477,037
+454,091
+1,979% +$32.8M
PEN icon
36
Penumbra
PEN
$10.5B
$31.9M 0.64%
+143,591
New +$31.9M
MORF
37
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$30.8M 0.62%
767,327
-69,194
-8% -$2.78M
ESTA icon
38
Establishment Labs
ESTA
$1.11B
$30.4M 0.61%
450,374
+44,833
+11% +$3.02M
ALNY icon
39
Alnylam Pharmaceuticals
ALNY
$58.6B
$29.4M 0.59%
+180,079
New +$29.4M
VRCA icon
40
Verrica Pharmaceuticals
VRCA
$49.4M
$29.3M 0.59%
3,610,412
– –
DICE
41
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$29M 0.58%
1,515,361
+810,476
+115% +$15.5M
MDGL icon
42
Madrigal Pharmaceuticals
MDGL
$9.7B
$27.3M 0.55%
278,286
+191,886
+222% +$18.8M
RCKT icon
43
Rocket Pharmaceuticals
RCKT
$358M
$26.6M 0.53%
1,678,090
-281,035
-14% -$4.46M
VRDN icon
44
Viridian Therapeutics
VRDN
$1.59B
$26.3M 0.53%
1,423,053
– –
NUVL icon
45
Nuvalent
NUVL
$5.74B
$24.3M 0.49%
1,751,601
+1,001,601
+134% +$13.9M
COGT icon
46
Cogent Biosciences
COGT
$1.83B
$23.9M 0.48%
3,188,750
– –
CMAX
47
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$23.8M 0.48%
3,186,663
-362,862
-10% -$2.71M
ZNTL icon
48
Zentalis Pharmaceuticals
ZNTL
$123M
$23.1M 0.46%
501,509
+70,965
+16% +$3.27M
OMIC
49
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$23.1M 0.46%
3,655,207
+321,383
+10% +$2.03M
LEGN icon
50
Legend Biotech
LEGN
$6.64B
$22.4M 0.45%
616,141
+427,041
+226% +$15.5M
1
2
3 4 5